LivaNova shares jump on earnings release
LivaNova (NSDQ:LIVN) today released earnings for the fiscal year 2015 and 4th quarter, as well as the transitional period for the recently merged Sorin Group and Cyberonics, seeing shares rise...
View ArticleCardiac Dimensions touts small Carillon mitral repair study
Cardiac Dimensions today touted the publication of a small study of its Carillon mitral valve repair system in the Journal of Invasive Cardiology, saying the device led to significant improvement in...
View ArticleConsumers hit social media with concerns over J&J’s talc powder
(Reuters) — Consumers expressed concern on social media about a talc-based baby powder made by Johnson & Johnson (NYSE:JNJ) today after a Missouri jury ordered the company to pay $72 million in...
View ArticleMassDevice.com +3 | The top 3 medtech stories for February 24, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticlePixium Vision touts 1st-in-human for Iris II retinal implant
French retinal implant maker Pixium Vision today announced the 1st implantation and successful activation of its Iris II epi-retinal implant designed for patients with vision loss as a result of...
View ArticleNxStage touts home hemodialysis studies
NxStage Medical (NSDQ:NXTM) today touted data from studies of its Nx2me connected health technology and home hemodialysis systems, which the company plans to present at the 2016 Annual Dialysis...
View ArticleSpectral Medical closes over-allotment, brings in $10.5m in round
Spectral Medical said today it closed an over-allotment on its most recent round of financing, selling an additional 806,804 shares at 70¢ per share to lift the round to $10.5 million Toronto-based...
View ArticleHedge fund buys 6% of RTI Surgical, looks to stack board
RTI Surgical said today that hedge fund group Krensavage Partners purchased approximately 3.4 million shares of stock, representing a total 6% of the company, and nominated a 4 healthcare vets for the...
View ArticleReva pulls in $11.4m, updates on Fantom II trial enrollment
Reva Medical (ASX:RVA) this month gave an update on its Fantom II trial, which has reached its target enrollment of 110 patients for its 1st cohort, and announced an incoming $11.4 million through a...
View ArticleThe history of clinical research eBook
For clinical research professionals, the protection of human subjects has always been of paramount importance. Doing so while ensuring accurate and credible data are obtained are the primary roles for...
View ArticleMedical device superstars: where innovation happens in the US
By Chris Schorre, Emergo Group Anyone who has worked in the medical device industry for more than 10 minutes knows there are certain states in the US buzzing with device activity. California,...
View ArticleBrazilian authorities raid Boston Scientific’s offices
Boston Scientific (NYSE:BSX) said yesterday that authorities in Brazil raided its subsidiary there as part of a probe into government contracts with the medical device maker. Marlborough, Mass.-based...
View ArticleMore layoffs ahead for Teleflex
Teleflex (NYSE:TFX) said today that it plans to lay off workers and consolidate operations as it looks to save $12 million to $16 million a year, nearly 2 years after announcing a similar plan to cut...
View ArticleBoston Scientific co-founder Peter Nicholas to step down a year ahead of plan
Boston Scientific (NYSE:BSX) co-founder and chairman Peter Nicholas said today that he’ll step down a year earlier than planned, amid a shakeup on the medical device maker’s board. Longtime directors...
View ArticleHeartWare takes another hit despite Q4, 2015 beats
HeartWare International (NSDQ:HTWR) shares took another hit today despite 4th-quarter results that topped expectations on Wall Street, as investors reacted to lower-than-expected sales volume overseas....
View ArticleInsulet, Mode AGC ink deal to develop artificial pancreas
Insulet (NSDQ:PODD) said today that it inked a deal with Mode Automated Glucose Control to develop an artificial pancreas using its flagship OmniPod device. The deal would see the Mode AGC algorithm...
View ArticleIncoming FDA chief Califf outlines priorities
Incoming FDA commissioner Dr. Robert Califf, confirmed yesterday by the U.S. Senate, said he plans to make recruiting and retaining talent his 1st priority. “That sounds maybe unusual, but I really...
View ArticleNIH Taps Google’s Verily for Vandy precision health project
The National Institute of Health today said Google‘s (NSDQ:GOOG) Verily, formerly the company’s Life Sciences division, will advise Nashville, Tenn.’s Vanderbilt University to launch the 1st phase of...
View ArticleMassDevice.com +3 | The top 3 medtech stories for February 25, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the...
View ArticleAccuray, GE Healthcare ink financing deal for Cyberknife, TomoTherapy
Accuray (NSDQ:ARAY) and GE Healthcare (NYSE:GE) said today they signed a collaborative agreement to develop financing options for Accuray’s CyberKnife and TomoTherapy systems. The companies said they...
View Article